50-245-533

Podocalyxin Monoclonal Antibody (B34D1.3), PE, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-245-533-Each-of-1 In Stock ₹ 27,234.00

50-245-533 - Each of 1

₹ 27,234.00

In Stock

Quantity

1

Base Price: ₹ 27,234.00

GST (18%): ₹ 4,902.12

Total Price: ₹ 32,136.12

Antigen

Podocalyxin

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

O00592

Gene Symbols

PODXL

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

5420

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

B34D1.3

Conjugate

PE

Gene

PODXL

Gene Alias

AW121214; GCTM-2 antigen; Gp200; Ly102; MGC138240; PC; PCLP; PCLP antibody; Pclp1; PCLP-1; PCLP1 antibody; PODLX2; podocalyxin; podocalyxin like; podocalyxin-like; podocalyxin-like protein 1; podolyxin; Podxl

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG2a κ

Related Products

Img

Invitrogen

61-567-942

--

Img

Invitrogen

50-500-142

--

Img

Invitrogen

50-168-58

--

Img

Invitrogen

50-985-6

--

Img

Invitrogen

63223942

--

Img

Invitrogen

53-317-942

--

Img

Invitrogen

63-166-842

--

Img

Invitrogen

63-986-842

--

Description

  • Description: The monoclonal antibody B34D1.3 recognizes human podocalyxin, a protein expressed on undifferentiated human embryonic stem cells (ES), embryonic carcinoma cells (EC), and embryonic germ cells (EG)
  • Podocalxyin is a heavily glycosylated cell adhesion protein with homology to CD34 and endoglycan
  • It was first identified on kidney podocytes, and then found to be upregulated in a variety of human cancers such as breast and prostate cancer
  • Like other stem cell-specific markers, the epitope recognized by the B34D1.3 antibody is lost upon cell differentiation
  • The B34D1.3 antibody recognizes the ectodomain of podocalyxin, which is a different epitope from the Tra-1-60 and Tra-1-81 monoclonal antibodies
  • While Tra1-60 has been found to react with a sialidase-sensitive epitope, the epitope recognized by Tra1-81 has not been fully defined
  • Applications Reported: This B34D1.3 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This B34D1.3 antibody has been pre-titrated and tested by flow cytometric analysis of the NTERA cell line
  • This can be used at 5 μL (0.5 μg) per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • Excitation: 488-561 nm; Emission: 578 nm; Laser: Blue Laser, Green Laser, Yellow-Green Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • This gene encodes a member of the sialomucin protein family
  • The encoded protein was originally identified as an important component of glomerular podocytes
  • Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane
  • Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin.